Kang, Heeseok <br/><br/>
Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a single-institutional phase II study.  [electronic resource] 

 -  Gynecologic oncology  Aug 2009 
 - 210-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2009.04.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Epithelial Cells--pathology<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Survival Rate<br/>Topotecan--administration & dosage